Pu Yan

MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity <i>in vitro</i> and <i>in vivo</i>

Marielle Fournel, Claire Bonfils, Yu Hou et al. · Molecular Cancer Therapeutics · 2008 · 336 citations · Full text

Medicine, Oncology, Pharmacology +13

Discovery of <i>N</i>-(2-Aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an Orally Active Histone Deacetylase Inhibitor

Nancy Zhou, Oscar Moradei, Stéphane Raeppel et al. · Journal of Medicinal Chemistry · 2008 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors

Giliane Bouchain, Silvana Leit, Sylvie Fréchette et al. · Journal of Medicinal Chemistry · 2003 · 72 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Design and synthesis of a novel class of histone deacetylase inhibitors

Rico Lavoie, Giliane Bouchain, Sylvie Fréchette et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +13

Background Staining of Visualization Systems in Immunohistochemistry

Bettine A.H. Vosse, Walter Seelentag, Astrid Bachmann et al. · Applied immunohistochemistry & molecular morphology · 2007 · 38 citations

Medicine, Pathology, Cellular Pathology +15